Radiology Clinical Trials

 

St. Jude Clinical Trials

DWSARC: Diffusion Weighted Magnetic Resonance Imaging In Pediatric Sarcomas

Diseases Treated:

Solid tumors

Eligibility:

This is a non-therapeutic clinical trial that is only open to St. Jude patients.

  • Participant is under the care of a St. Jude physician with a known or suspected, newly diagnosed bone or soft tissue sarcoma who will be treated on or as per disease specific protocols and has not begun therapy OR participant has started therapy and the needed research imaging can be performed within 2-5 days of starting treatment. 
  • Participant has undergone or is scheduled for PET-CT, Bone Scan, or PET-CT and Bone Scan within two (2) weeks of the whole body and primary tumor DWI-MRI. 
  • Participant meets institutional MRI safety screening requirements. 
  • Participant has not undergone primary tumor resection prior to arrival to St. Jude
View Trial

RERTEP: Surgery and Second-Course Radiation Therapy in Treating Younger Patients With Recurrent Ependymoma

Diseases Treated:

Recurrent ependymoma

Eligibility:

  • Progressive intracranial ependymoma after prior focal irradiation
  • At least 1 year old and younger than 21 years old
  • Adequate performance status (ECOG less than 3)
  • Does not require mechanical ventilation
  • Interval from start of initial radiation therapy to enrollment greater than 9 months
View Trial

RMS13: Chemotherapy, Surgery, and Radiation Therapy in Treating Patients with Newly Diagnosed, Localized Rhabdomyosarcoma

Diseases Treated:

Rhabdomyosarcoma (low-risk, intermediate-risk and high-risk)

Eligibility:

  • Must have newly diagnosed rhabdomyosarcoma
  • Less than 22 years of age
  • Has not received previous treatment with chemotherapy or radiation therapy
View Trial

RT2CR: Limited Surgery and Proton Beam Radiation Therapy in Treating Younger Patients with Brain Tumors

Diseases Treated:

Craniopharyngioma

Eligibility:

  • 21 years of age or younger
  • Diagnosis of craniopharyngioma 
  • Has not been previously treated with radiation therapy
View Trial

RT3CR: Proton Therapy for Pediatric Craniopharyngioma

Diseases Treated:

Craniopharyngioma

Eligibility:

  • 21 years old or younger
  • Diagnosis of craniopharyngioma
View Trial